Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2025-12-25 @ 8:22 PM
Study NCT ID:
NCT04338269
Status:
COMPLETED
Last Update Posted:
2025-04-04
First Post:
2020-04-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-28
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03-24
Completion Date Type:
ACTUAL
First Submit Date:
2020-04-06
First Submit QC Date:
None
Study First Post Date:
2020-04-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-12-20
Results First Submit QC Date:
None
Results First Post Date:
2024-02-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-27
Last Update Post Date:
2025-04-04
Last Update Post Date Type:
ACTUAL